CREBBP c.3148G>A ;(p.E1050K)

Variant ID: 16-3817823-C-T

NM_004380.2(CREBBP):c.3148G>A;(p.E1050K)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS.

Oncotargets And Therapy
Luo, Shuna S; Xu, Xiaofei X; Ye, Xingnong X; Zhu, Xiaoqiong X; Wu, Cai C; Chen, Dan D; Jin, Jingxia J; Zheng, Yan Y; Zheng, Mengli M; Huang, Jian J
Publication Date: 2020

Variant appearance in text: CREBBP: 3148G>A; E1050k
PubMed Link: 33116596
Variant Present in the following documents:
  • Main text
  • ott-13-10143.pdf
View BVdb publication page



Phase and context shape the function of composite oncogenic mutations.

Nature
Gorelick, Alexander N AN; Sánchez-Rivera, Francisco J FJ; Cai, Yanyan Y; Bielski, Craig M CM; Biederstedt, Evan E; Jonsson, Philip P; Richards, Allison L AL; Vasan, Neil N; Penson, Alexander V AV; Friedman, Noah D ND; Ho, Yu-Jui YJ; Baslan, Timour T; Bandlamudi, Chaitanya C; Scaltriti, Maurizio M; Schultz, Nikolaus N; Lowe, Scott W SW; Reznik, Ed E; Taylor, Barry S BS
Publication Date: 2020-06

Variant appearance in text: CREBBP: E1050K
PubMed Link: 32461694
Variant Present in the following documents:
  • NIHMS1582596-supplement-1582596_Supp_Tab1-5.xlsx, sheet 2
View BVdb publication page



Sequencing of Lynch syndrome tumors reveals the importance of epigenetic alterations.

Oncotarget
Porkka, Noora N; Valo, Satu S; Nieminen, Taina T TT; Olkinuora, Alisa A; Mäki-Nevala, Satu S; Eldfors, Samuli S; Peltomäki, Päivi P
Publication Date: 2017-12-08

Variant appearance in text: CREBBP: E1050K
PubMed Link: 29296220
Variant Present in the following documents:
  • oncotarget-08-108020-s006.xlsx, sheet 1
View BVdb publication page